查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2034929

全球週邊靜脈導管市場：市場規模、佔有率和趨勢分析（2026-2032 年）

Peripheral Intravenous Catheters Market Size, Share & Trends Analysis | Global | 2026-2032 | Includes: Conventional and Safety Catheters
出版日期: | 出版商: iData Research Inc. | 英文 96 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球週邊靜脈導管市場報告（至2032年）

2025年全球週邊靜脈導管市場規模為17億美元。預計到2032年，該市場將以2.1%的複合年成長率成長，達到19億美元。

本報告涵蓋了週邊靜脈導管（PIVC）的全球市場，包括用於急性護理和替代醫學環境的傳統PIVC和安全增強型PIVC。

分析內容包括銷售量、平均售價 (ASP)、手術數量、市場規模、市場佔有率、成長趨勢、到 2032 年的市場預測以及到 2022 年的歷史數據。

市場成長主要得益於教育計畫的推出、超音波引導下週邊靜脈置管（PIVC）套件和安全裝置的普及，以及PIVC在醫療機構的持續應用。然而，對專用固定裝置的需求以及PIVC留置時間的延長，導致每位患者使用的導管數量減少，從而限制了市場的進一步擴張。

市場概覽

全球週邊靜脈導管市場包括用於藥物輸注、液體輸注、血液採樣和常規醫院護理的短期靜脈通路裝置。

市場細分將週邊靜脈留置針（PIVC）分為傳統PIVC和安全型PIVC。安全型PIVC旨在保護醫護人員和患者免受針刺傷。安全型PIVC包括可防止血液飛濺的血液控制型PIVC和非血液控制型PIVC。

此外，市場細分也按醫療保健環境分類，例如急診和替代醫學。週邊靜脈留置針（PIVC）是最常用的靜脈通路裝置產品類型，在醫院、診所、急診和其他治療機構中消耗量龐大。

隨著臨床指徵的拔管日益普遍，週邊靜脈留置時間也隨之延長。以往按固定時間表更換導管的做法，如今只有在出現併發症或治療結束後才會拔除。這減少了不必要的導管更換，降低了每位患者使用的導管數量，從而限制了導管使用量的成長，儘管其應用廣泛。

市場促進因素

為教育目的而進行的留校

用於教學目的的週邊靜脈置管術持續支撐著產品需求。醫生、護士和其他醫療保健專業人員需要持續接受血管通路技術的訓練。

這在包括超音波引導下置管在內的特殊置管技術中尤其重要。在臨床醫生的培訓、教育、模擬和監督實踐中，可以使用額外的週邊靜脈置管。

儘管由於外周靜脈留置時間的延長，每位患者使用的導管數量有所減少，但其在教育用途上的應用正在緩解這種下降趨勢的影響。與訓練相關的導管置入需求支撐了週邊靜脈留置導管的持續需求，尤其是在醫院和醫療機構等工作人員學習新置入技術的地方。

超音波引導下週邊靜脈置管試劑盒

超音波引導下週邊靜脈置管（PIVC）套件也是推動市場價值成長的因素之一。傳統上，PIVC 並不常以套件形式出售。 2015 年 11 月，貝朗公司推出了「Ster-ASSIST™ 外周靜脈導管置入套件」，其中包含超音波引導下 PIVC 置入所需的組件。

此套裝包含無菌超音波凝膠、超音波探頭保護套和一根長款Introcan Safety®週邊靜脈留置針（PIVC）。這些套裝的價格通常高於單獨購買的PIVC，根據訂購數據，此類套裝的平均售價（ASP）可超過200美元。

週邊靜脈置管（PIVC）工具包的普及與超音波引導下PIVC置管的數量密切相關。急診部醫生，尤其是已經使用超音波導引進行其他類型導管置入的醫生，是潛在的使用者群體之一。隨著超音波引導下PIVC置管的日益普及，高階工具包可望推動其市場價值的成長。

安全與出血控制轉型

安全型外周靜脈留置針透過降低針刺傷風險，持續支撐著市場。這些裝置內建安全機制，可在插入後保護醫護人員和病患。

具有防血濺功能的週邊靜脈留置針（PIVC）可透過減少插入過程中的血濺，帶來更多益處。這不僅改善了醫護人員的工作環境，減少了清理工作量，還能在病患眾多、繁忙的環境中實現更安全的工作流程。

隨著安全性和血液飛濺防護裝置取代傳統週邊靜脈留置針，市場正受益於平均售價較高的產品。雖然許多已開發地區的轉型正在進行中，但欠成熟市場仍存在市場接受度提升的空間，以及持續的產品升級，都可能繼續支撐市場價值。

市場限制

專用PIVC固定裝置

專用週邊靜脈留置針（PIVC）固定裝置是PIVC市場的重要限制因素。非計劃性重新插入是指在一個或多個現有裝置失效後必須插入新的PIVC的情況。

大約40%至70%的週邊靜脈置管是由於計劃外重新置入造成的。專用的週邊靜脈置管固定裝置旨在透過提高導管穩定性來減少此類失敗。

隨著專用固定裝置的普及，非計劃性再次置入的次數預計將會減少。這將降低每位患者使用的週邊靜脈留置針數量，從而抑制外周靜脈留置針市場的整體成長。

延長週邊靜脈留置時間

另一個主要限制因素是植入時間延長。植入時間越長，整個治療期間每位患者使用的週邊靜脈留置針數量就越少。

這一趨勢是由「臨床指徵拔除」政策所推動的。該政策建議僅在出現併發症或治療完成後才拔除導尿管，而不是遵循固定的拔管時間表。

這種方法減少了不必要的更換，提高了護理效率，但同時也減少了設備的總使用數量。隨著臨床指徵的移除變得越來越普遍，銷售成長可能仍將保持低迷。

成熟的大眾需求

週邊靜脈留置針（PIVC）市場是一個成熟且需求量大的領域。 PIVC廣泛應用於各種醫療機構，並已成為大多數醫院的標準血管通路工具。

由於該產品已被廣泛使用，其成長較少依賴於獲取新用戶，而更多地依賴產品範圍的改進、安全性的提高以及血液管理和超音波引導試劑盒等高級技術。

這種成熟度限制了市場的快速擴張。即使市場規模擴大，預計大部分成長也將來自高附加價值器械類別，而非導管總數的顯著增加。

市場覆蓋範圍和數據範圍

  • 量化範圍：市場規模、市場佔有率、手術數量、市場預測、市場成長率、銷售單位數量、平均售價。
  • 定性範圍：市場促進因素和限制因素、競爭分析、近期併購、公司簡介、產品系列和主要競爭對手。
  • 目標時期：基準年為 2025 年，預測至 2032 年，歷史資料截至 2022 年。
  • 建立市場模型：根據手術數量、競爭市場佔有率分析和預測假設，使用銷售量和平均售價 (ASP) 分析收入。
  • 目標器械：本報告涵蓋週邊靜脈導管，包括傳統週邊靜脈導管（PIVC）和安全型週邊靜脈導管。安全型週邊靜脈導管又分為血控型和非血控型兩種。此外，本報告也對急診和替代醫學領域的市場進行了分析。

目標市場及區隔

週邊靜脈導管市場

  • 設備類型：常規型和安​​全型。

傳統週邊靜脈導管（PIVC）是用於短期血管通路的標準週邊靜脈導管。雖然這些產品在全球市場仍佔有一席之地，尤其是在注重成本的醫療機構中，但在安全設備轉型升級的地區，其市場佔有率正在下降。

安全型外周靜脈留置針旨在降低針刺傷的風險。這些產品在許多醫療機構中逐漸成為標準配置，包括血控型和非血控型兩種類型。

血控式週邊靜脈留置針旨在防止插入和使用過程中血液飛濺。這些裝置能夠實現更安全、更清潔的臨床工作流程，並且通常比基本的傳統裝置具有更高的平均售價。

非血液控制型安全性週邊靜脈留置針配有安全機制，可降低針刺傷的風險，但不具備血液控制功能。

  • 醫療環境：急診和替代醫學。

急性護理場所包括醫院和急診科，這些場所廣泛使用週邊靜脈留置針（PIVC）以確保患者能夠即時獲得短期血液供應。其他醫療場所包括門診、醫療辦公室和非醫院醫療機構，這些場所也可能使用PIVC進行特定治療。

每個細分市場都以市場規模、市場佔有率、手術數量、市場預測、市場成長率、銷售量和平均售價進行分析。

競爭分析

2025年，貝克頓·迪金森公司引領了全球週邊靜脈留置針（PIVC）市場。該公司在向安全性更高、血液管理能力更強的PIVC過渡的過程中發揮了關鍵作用。

BD的產品線涵蓋關鍵市場領域，該公司在非血液控制安全領域處於領先地位，這主要得益於其Insyte® Autoguard®導管的銷售。在血液控制領域，BD銷售Nexiva™裝置和Insyte® Autoguard®血液控制導管。

貝朗公司憑藉Introcan Safety®靜脈導管和Introcan Safety® 3封閉式靜脈導管等產品，在安全型週邊靜脈留置針（PIVC）市場中競爭。這些裝置與傳統PIVC類似，但具有自動且不可旁路的安全功能。

貝朗公司正透過推出低成本的週邊靜脈導管（PIVC）來擴大市場佔有率。該公司推出的Ster-ASSIST™外周靜脈導管置入套件順應了超音波超音波尚未普及。

2025年，ICU Medical在週邊靜脈留置針（PIVC）市場排名第三。該公司提供常規產品和安全型產品。其「Jelco® Protect IV®」在安全型產品領域與BD的「Insyte® Autoguard®」競爭。 ICU Medical收購Smiths Medical後，進一步鞏固了其市場地位；其採用Ocrilon®聚氨酯材料製成的「OPTIVA®」旨在降低靜脈炎的風險。

技術和臨床趨勢

安全週邊靜脈留置針的推廣

在許多市場，安全型週邊靜脈留置針正逐漸取代傳統產品。這些裝置降低了針刺傷的風險，並有助於實現更安全的臨床工作流程。

轉型為安全導向型設備仍然是改善產品組合的關鍵因素，尤其是在傳統設備仍在使用的市場中。

血液飛濺預防技術

具有防血濺功能的週邊靜脈留置針（PIVC）正變得越來越重要，因為它們有助於減少插入過程中的血濺。這提高了使用者的便利性，並有助於控制感染和提高工作流程效率。

這些裝置的平均售價（ASP）通常高於基本安全型PIVC。

根據臨床指徵移除

由於臨床指徵的改變，週邊靜脈留置針的使用模式正在改變。現在擴大在治療結束時或出現併發症時移除外周靜脈留置針，而不是按照固定的更換計劃進行。

這提高了護理效率，但減少了每位患者使用的週邊靜脈留置針數量。

超音波引導下插入

對於血管通路困難的患者，超音波導引下週邊靜脈置管術（PIVC）的重要性日益凸顯。專為超音波引導下置管設計的試劑盒價格可能較高。

是否實施取決於訓練情況、醫生和護士的偏好以及超音波引導下週邊靜脈置管的頻率。

固定裝置的影響

專用固定裝置可減少非計劃性重新插入。這些產品透過穩定導管，減少導管故障和重新插入次數。

雖然這將改善患者照護，但也會抑制對週邊靜脈留置針的需求。

材料改進

材料的改進不斷提升設備的性能。 ICU Medical 的 OPTIVA® 導管採用 Ocrilon® 聚氨酯製成，其產品設計旨在降低靜脈炎的風險，就是一個例證。

改進材料有助於在成熟市場中實現產品差異化。

地區

本報告涵蓋全球範圍，包括北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。

這份報告的意義

  • 目前全球週邊靜脈導管市場規模有多大？預計到 2032 年將成長多少？
  • 在預測期內，傳統週邊靜脈置管（PIVC）市場和安全週邊靜脈置管（PIVC）市場是如何發展的？
  • 隨著時間的推移，銷售量、治療量、平均售價（ASP）和市場規模發生了什麼樣的變化？
  • PIVC 在血液管理中對產品組合成長和平均售價 (ASP) 起什麼作用？
  • 臨床指徵的拔除對 PIVC 的使用時間與需求有何影響？
  • 為什麼專用固定裝置可以減少非計劃性再次植入？
  • 超音波導引下週邊靜脈置管試劑盒對高級產品的採用產生了怎樣的影響？
  • 培訓和教育計畫在滿足不斷成長的導管需求方面發揮著什麼作用？
  • 全球PIVC市場的主要參與者有哪些公司？
  • BD、B. Braun 和 ICU Medical 在傳統的、以安全為導向的、以血液管理為導向的和超音波引導的 PIVC產品類型中分別處於什麼位置？

iData Research 的「全球週邊靜脈導管市場報告」透過設備層級分析、基於手術的建模、平均售價 (ASP) 數據、企業市場占有率分析以及到 2032 年的預測來解答這些問題。本報告可用於評估需求、與競爭對手進行基準比較、了解向安全導管過渡的趨勢，並協助您制定全球 PIVC 市場的產業計畫。

目錄

調查方法

  • 步驟 1：專案啟動與團隊組建
  • 步驟 2：準備資料系統並進行二次調查。
  • 步驟 3：設計和準備訪談和調查問卷。
  • 步驟 4：進行初步調查
  • 步驟 5：調查與分析：建立基準估計值
  • 步驟 6：市場預測與分析
  • 步驟 7：辨識策略機遇
  • 步驟 8：最終審核和市場推廣
  • 步驟 9：客戶回饋與市場監測

全球關稅的影響

週邊靜脈導管市場

  • 摘要整理
    • 全球週邊靜脈導管市場概覽
    • 競爭分析
    • 目標程式
    • 目標市場
    • 目標區域
  • 介紹
  • 手術次數
    • 整體週邊靜脈導管置入術
  • 市場概覽
    • 按細分市場
    • 按地區
  • 市場分析與預測
    • 週邊靜脈導管市場整體狀況
    • 傳統週邊靜脈導管市場
    • 安全週邊靜脈導管市場
  • 促進因素和抑制因素
  • 競爭性市佔率分析

簡稱

Product Code: iDATA_GLVA26_PI_MC

Global Peripheral Intravenous Catheter Market Report to 2032

The global peripheral intravenous catheter market was valued at $1.7 billion in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 2.1%, reaching $1.9 billion by 2032.

This report covers the global market for peripheral intravenous catheters (PIVCs), including conventional and safety PIVCs used across acute care and alternate care settings.

The analysis includes unit sales, average selling prices (ASPs), procedure numbers, market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.

Market growth is supported by educational placement, ultrasound-guided PIVC kits, safety device conversion, and continued use of PIVCs across healthcare settings. However, specialized securement devices and increasing PIVC dwell times are reducing the number of catheters used per patient, limiting stronger market expansion.

Market Overview

The global peripheral intravenous catheter market includes short-term vascular access devices used for medication delivery, fluid administration, blood draws, and routine hospital care.

The market is segmented into conventional and safety PIVCs. Safety PIVCs are designed to protect healthcare professionals and patients against needlestick injuries. The safety segment includes blood control PIVCs, which help protect against blood splatter, and non-blood control PIVCs.

The market is also segmented by care setting, including acute care and alternate care. PIVCs are among the most commonly used vascular access devices, making them a high-volume product category across hospitals, clinics, emergency departments, and other treatment settings.

PIVC dwell times continue to lengthen as clinically indicated removal becomes more widely adopted. Instead of replacing catheters on a fixed schedule, PIVCs are increasingly removed only when a complication occurs or therapy ends. This reduces unnecessary line replacements and lowers the number of PIVCs used per patient, constraining unit volume growth despite widespread use.

Market Drivers

Placement for Educational Purposes

PIVC placement for educational purposes continues to support unit demand. Physicians, nurses, and other healthcare professionals require ongoing training in vascular access techniques.

This is especially relevant for specialized placement methods, including ultrasound-guided insertion. As clinicians receive training, additional PIVCs may be used during education, simulation, and supervised practice.

Although PIVC dwell time trends are reducing the number of catheters used per patient, educational use helps moderate the effect of that decline. Training-related placements support continued demand for PIVCs, particularly in hospitals and care settings where staff are learning new insertion techniques.

Ultrasound-Guided PIVC Kits

Ultrasound-guided PIVC kits are another driver of market value. Historically, PIVCs were not commonly sold in kits. In November 2015, B. Braun launched the Ster-ASSIST(TM) Peripheral IV Catheter Insertion Kit, which includes components for ultrasound-guided PIVC insertion.

The kit includes sterile ultrasound gel, an ultrasound probe cover, and a long Introcan Safety(R) PIVC. These kits generally command a price premium over standalone PIVCs, with purchase order data indicating that ASPs for such kits can exceed $200.

Adoption of PIVC kits is linked to the volume of PIVC insertions performed using ultrasound guidance. Emergency room physicians, who already use ultrasound to guide placement of other catheter types, represent one potential adoption group. If ultrasound-guided PIVC insertion becomes more common, premium kits could support market value growth.

Safety and Blood Control Conversion

Safety PIVCs continue to support the market by reducing needlestick injury risk. These devices include built-in safety mechanisms that protect healthcare professionals and patients after insertion.

Blood control PIVCs provide an additional benefit by helping reduce blood splatter during placement. This can improve clinician experience, reduce cleanup, and support safer workflows in high-volume settings.

As safety and blood control devices replace conventional PIVCs, the market benefits from higher ASP products. While conversion is advanced in many developed regions, remaining adoption opportunities in less mature markets and ongoing product upgrades can continue supporting market value.

Market Limiters

Specialized PIVC Securement Devices

Specialized PIVC securement devices are an important limiter for the PIVC market. An unscheduled restart occurs when a new PIVC must be inserted after one or more previous devices fail.

Approximately 40% to 70% of total PIVC insertions are attributed to unscheduled restarts. Specialized PIVC securement devices are designed to reduce these failures by improving catheter stability.

As penetration of specialized securement devices increases, the volume of unscheduled restarts is expected to decline. This reduces the number of PIVCs used per patient and limits growth in the total PIVC market.

Increased PIVC Dwell Time

Increased dwell time is another major restraint. Longer dwell times mean fewer PIVCs are used per patient over the course of care.

This trend is driven by clinically indicated removal, a policy that recommends removing catheters only when a complication occurs or therapy ends, rather than on a fixed schedule.

While this approach reduces unnecessary replacements and improves care efficiency, it also lowers total unit consumption. As clinically indicated removal becomes more common, unit sales growth will remain constrained.

Mature High-Volume Demand

The PIVC market is a mature, high-volume category. PIVCs are widely used across care settings, and most hospitals already rely on them as a standard vascular access tool.

Because the product is already broadly adopted, growth is less dependent on new users and more dependent on product mix, safety conversion, and premium technologies such as blood control and ultrasound-guided kits.

This maturity limits rapid expansion. Even when market value grows, much of the growth is expected to come from higher-value device categories rather than strong increases in total catheter volume.

Market Coverage and Data Scope

  • Quantitative coverage: Market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.
  • Qualitative coverage: Market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios, and leading competitors.
  • Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
  • Market modeling: Revenue is analyzed using unit sales and ASPs, supported by procedure numbers, competitive share analysis, and forecast assumptions.
  • Device scope: The report covers peripheral intravenous catheters, including conventional and safety PIVCs. The safety segment includes blood control and non-blood control PIVCs. The market is also analyzed across acute care and alternate care settings.

Markets Covered and Segmentation

Peripheral Intravenous Catheter Market

  • Device type: Conventional and safety.

Conventional PIVCs are standard peripheral intravenous catheters used for short-term vascular access. These products remain part of the global market, particularly in cost-sensitive settings, but their share has declined in regions where safety device conversion is advanced.

Safety PIVCs are designed to reduce needlestick injury risk. These products are increasingly standard in many healthcare settings and include both blood control and non-blood control variants.

Blood control PIVCs are designed to protect against blood splatter during insertion and use. These devices support safer and cleaner clinical workflows and typically command higher ASPs than basic conventional devices.

Non-blood control safety PIVCs include safety mechanisms to reduce needlestick injury risk but do not include the same blood control functionality.

  • Care setting: Acute care and alternate care.

Acute care settings include hospitals and emergency departments where PIVCs are used at high volume for immediate and short-term access. Alternate care settings include outpatient, clinic, and non-hospital care environments where PIVCs may be used for selected treatments.

Each segment is analyzed by market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.

Competitive Analysis

In 2025, Becton Dickinson led the global PIVC market. The company has played a major role in the conversion to safety and blood control PIVCs.

BD's offerings cover major segments of the market, and the company is the leader of the non-blood control safety segment, driven largely by sales of Insyte(R) Autoguard(R) catheters. In the blood control segment, BD sells Nexiva(TM) devices and Insyte(R) Autoguard(R) BC.

B. Braun competes in the safety PIVC market through products such as Introcan Safety(R) IV catheters and Introcan Safety(R) 3 closed IV catheters. These devices resemble conventional PIVCs while offering automatic and unbypassable safety features.

B. Braun has gained share partly through lower-priced PIVCs. Its Ster-ASSIST(TM) peripheral IV catheter insertion kit also aligns with the trend toward ultrasound-guided PIVC insertion, even without major organization-wide endorsements for ultrasound guidance.

ICU Medical ranked third in the PIVC market in 2025. The company offers both conventional and safety products. Jelco(R) ProtectIV(R) competes with BD's Insyte(R) Autoguard(R) in the safety segment. ICU Medical's acquisition of Smiths Medical strengthened its position, while OPTIVA(R), made from Ocrilon(R) polyurethane, is designed to reduce phlebitis risk.

Technology and Practice Trends

Safety PIVC Adoption

Safety PIVCs continue to replace conventional products in many markets. These devices reduce needlestick injury risk and support safer clinical workflows.

Safety conversion remains an important source of product mix improvement, especially in markets where conventional devices are still used.

Blood Control Technology

Blood control PIVCs are gaining importance because they help reduce blood splatter during insertion. This improves user experience and supports infection control and workflow efficiency.

These devices generally command higher ASPs than basic safety PIVCs.

Clinically Indicated Removal

Clinically indicated removal is changing utilization patterns. PIVCs are increasingly removed when therapy ends or when complications occur, rather than according to fixed replacement schedules.

This improves care efficiency but reduces the number of PIVCs used per patient.

Ultrasound-Guided Insertion

Ultrasound-guided PIVC insertion is becoming more relevant for patients with difficult vascular access. Kits designed for ultrasound-guided insertion can command meaningful price premiums.

Adoption depends on training, physician and nurse preference, and the frequency of ultrasound-guided PIVC placement.

Securement Device Impact

Specialized securement devices are reducing unscheduled restarts. By helping keep catheters stable, these products lower the number of failed lines and repeat insertions.

This benefits patient care but limits PIVC unit demand.

Material Improvements

Material improvements continue to support device performance. ICU Medical's OPTIVA(R) catheter, made from Ocrilon(R) polyurethane, is an example of product design aimed at reducing phlebitis risk.

Improved materials can help differentiate products in a mature market.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

  • How large is the global peripheral intravenous catheter market today, and how much is it expected to grow through 2032?
  • How are conventional and safety PIVC segments performing across the forecast period?
  • How are unit sales, procedure numbers, ASPs, and market values changing over time?
  • What role do blood control PIVCs play in product mix and ASP growth?
  • How is clinically indicated removal affecting PIVC dwell time and unit demand?
  • Why are specialized securement devices reducing unscheduled restarts?
  • How are ultrasound-guided PIVC kits influencing premium product adoption?
  • What role does training and educational placement play in ongoing catheter demand?
  • Which companies lead the global PIVC market?
  • How are BD, B. Braun, and ICU Medical positioned across conventional, safety, blood control, and ultrasound-guided PIVC product categories?

The Global Peripheral Intravenous Catheter Market Report from iData Research answers these questions with device-level analysis, procedure-based modeling, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand safety conversion trends, and support commercial planning in the global PIVC market.

TABLE OF CONTENT

Research Methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems And Perform Secondary Research
  • Step 3: Preparation For Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast And Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review And Market Release
  • Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Peripheral Intravenous Catheter Market

  • 8.1 Executive Summary
    • 8.1.1 Global Peripheral Intravenous Catheter Market Overview
    • 8.1.2 Competitive Analysis
    • 8.1.3 Procedures Included
    • 8.1.4 Markets Included
    • 8.1.5 Regions Included
  • 8.2 Introduction
  • 8.3 Procedure Numbers
    • 8.3.1 Total Peripheral Intravenous Catheter Procedures
  • 8.4 Market Overview
    • 8.4.1 By Segment
    • 8.4.2 By Region
  • 8.5 Market Analysis And Forecast
    • 8.5.1 Total Peripheral Intravenous Catheter Market
    • 8.5.2 Conventional Peripheral Intravenous Catheter Market
    • 8.5.3 Safety Peripheral Intravenous Catheter Market
      • 8.5.3.1 Blood-Control Catheter Market
      • 8.5.3.1.1 Integrated Catheter Market
      • 8.5.3.1.2 Non-Integrated Catheter Market
      • 8.5.3.2 Non-Blood Control Catheter Market
      • 8.5.3.2.1 Non-Blood Control Active Catheter Market
      • 8.5.3.2.2 Non-Blood Control Passive Catheter Market
  • 8.6 Drivers And Limiters
    • 8.6.1 Market Drivers
    • 8.6.2 Market Limiters
  • 8.7 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

  • Chart 8-1: Peripheral Intravenous Catheter Market, Global, 2025 & 2032
  • Chart 8-2: Peripheral Intravenous Catheter Procedures, Global, 2025
  • Chart 8-3: Peripheral Intravenous Catheter Procedures by Region, Global, 2022 - 2032
  • Chart 8-4: Peripheral Intravenous Catheter Market by Segment, Global, 2022 - 2032
  • Chart 8-5: Peripheral Intravenous Catheter Market by Region, Global, 2022 - 2032
  • Chart 8-6: Leading Competitors, Peripheral Intravenous Catheter Market, Global, 2025

LIST OF FIGURES

  • Figure 8-1: Peripheral Intravenous Catheter Procedures Covered
  • Figure 8-2: Peripheral Intravenous Catheter Markets Covered
  • Figure 8-3: Peripheral Intravenous Catheter Regions Covered, Global (1 of 2)
  • Figure 8-4: Peripheral Intravenous Catheter Regions Covered, Global (2 of 2)
  • Figure 8-5: Peripheral Intravenous Catheter Procedures by Region, Global, 2022 - 2032
  • Figure 8-6: Peripheral Intravenous Catheter Procedures by Country, North America, 2022 - 2032
  • Figure 8-7: Peripheral Intravenous Catheter Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 8-8: Peripheral Intravenous Catheter Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 8-9: Peripheral Intravenous Catheter Procedures by Country, Western Europe, 2022 - 2032 (1 of 2)
  • Figure 8-10: Peripheral Intravenous Catheter Procedures by Country, Western Europe, 2022 - 2032 (2 of 2)
  • Figure 8-11: Peripheral Intravenous Catheter Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 8-12: Peripheral Intravenous Catheter Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 8-13: Peripheral Intravenous Catheter Procedures by Country, Middle East, 2022 - 2032
  • Figure 8-14: Peripheral Intravenous Catheter Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 8-15: Peripheral Intravenous Catheter Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 8-16: Peripheral Intravenous Catheter Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 8-17: Peripheral Intravenous Catheter Procedures by Country, Africa, 2022 - 2032
  • Figure 8-18: Peripheral Intravenous Catheter Market by Segment, Global, 2022 - 2032 (US$M)
  • Figure 8-19: Peripheral Intravenous Catheter Market by Region, Global, 2022 - 2032 (US$M)
  • Figure 8-20: Peripheral Intravenous Catheter Market, Global, 2022 - 2032
  • Figure 8-21: Units Sold by Region, Peripheral Intravenous Catheter Market, Global, 2022 - 2032
  • Figure 8-22: Average Selling Price by Region, Peripheral Intravenous Catheter Market, Global, 2022 - 2032 (US$)
  • Figure 8-23: Market Value by Region, Peripheral Intravenous Catheter Market, Global, 2022 - 2032 (US$M)
  • Figure 8-24: Conventional Peripheral Intravenous Catheter Market, Global, 2022 - 2032
  • Figure 8-25: Units Sold by Region, Conventional Peripheral Intravenous Catheter Market, Global, 2022 - 2032
  • Figure 8-26: Average Selling Price by Region, Conventional Peripheral Intravenous Catheter Market, Global, 2022 - 2032 (US$)
  • Figure 8-27: Market Value by Region, Conventional Peripheral Intravenous Catheter Market, Global, 2022 - 2032 (US$M)
  • Figure 8-28: Safety Peripheral Intravenous Catheter Market by Segment, Global, 2022 - 2032 (US$M)
  • Figure 8-29: Total Safety PIVC Market, Global, 2022- 2032
  • Figure 8-30: Units Sold by Region, Safety PIVC Market, Global, 2022- 2032
  • Figure 8-31: Average Selling Price by Region, Safety PIVC Market, Global, 2022- 2032 (US$)
  • Figure 8-32: Market Value by Region, Hemodialysis Catheter Market, Global, 2022- 2032 (US$M)
  • Figure 8-33: Blood-Control Catheter Market by Segment, Global, 2022 - 2032 (US$M)
  • Figure 8-34: Total Blood-Control Catheter Market, Global, 2022- 2032
  • Figure 8-35: Units Sold by Region, Blood-Control Catheter Market, Global, 2022- 2032
  • Figure 8-36: Average Selling Price by Region, Blood-Control Catheter Market, Global, 2022- 2032 (US$)
  • Figure 8-37: Market Value by Region, Blood-Control Catheter Market, Global, 2022- 2032 (US$M)
  • Figure 8-38: Integrated Catheter Market, Global, 2022 - 2032
  • Figure 8-39: Units Sold by Region, Integrated Catheter Market, Global, 2022 - 2032
  • Figure 8-40: Average Selling Price by Region, Integrated Catheter Market, Global, 2022 - 2032 (US$)
  • Figure 8-41: Market Value by Region, Integrated Catheter Market, Global, 2022 - 2032 (US$M)
  • Figure 8-42: Non-Integrated Catheter Market, Global, 2022- 2032
  • Figure 8-43: Units Sold by Region, Non-Integrated Catheter Market, Global, 2022 - 2032
  • Figure 8-44: Average Selling Price by Region, Non-Integrated Catheter Market, Global, 2022 - 2032 (US$)
  • Figure 8-45: Market Value by Region, Non-Integrated Catheter Market, Global, 2022 - 2032 (US$M)
  • Figure 8-46: Non-Blood Control Catheter Market by Segment, Global, 2022 - 2032 (US$M)
  • Figure 8-47: Total Non-Blood Control Catheter Market, Global, 2022- 2032
  • Figure 8-48: Units Sold by Region, Non-Blood Control Catheter Market, Global, 2022- 2032
  • Figure 8-49: Average Selling Price by Region, Non-Blood Control Catheter Market, Global, 2022- 2032 (US$)
  • Figure 8-50: Market Value by Region, Non-Blood Control Catheter Market, Global, 2022- 2032 (US$M)
  • Figure 8-51: Non-Blood Control Active Catheter Market, Global, 2022 - 2032
  • Figure 8-52: Units Sold by Region, Non-Blood Control Active Catheter Market, Global, 2022 - 2032
  • Figure 8-53: Average Selling Price by Region, Non-Blood Control Active Catheter Market, Global, 2022 - 2032 (US$)
  • Figure 8-54: Market Value by Region, Non-Blood Control Active Catheter Market, Global, 2022 - 2032 (US$M)
  • Figure 8-55: Non-Blood Control Passive Catheter Market, Global, 2022 - 2032
  • Figure 8-56: Units Sold by Region, Non-Blood Control Passive Catheter Market, Global, 2022 - 2032
  • Figure 8-57: Average Selling Price by Region, Non-Blood Control Passive Catheter Market, Global, 2022 - 2032 (US$)
  • Figure 8-58: Market Value by Region, Non-Blood Control Passive Catheter Market, Global, 2022 - 2032 (US$M)
  • Figure 8-59: Leading Competitors, Peripheral Intravenous Catheter Market, Global, 2025